IDK1 is a rat monoclonal antibody against hypoglycosylated bone sialoprotein with application as biomarker and therapeutic agent in breast cancer skeletal metastasis

Changes in glycosylation are salient features of cancer cells. Here, we report on the diagnostic and therapeutic properties of IDK1, an antibody against tumour associated, hypoglycosylated bone sialoprotein (hypo‐BSP). The affinity of the rat monoclonal antibody IDK1 for hypo‐BSP, as determined by m...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:J Pathol Clin Res
Hauptverfasser: Zepp, Michael, Kovacheva, Marineta, Altankhuyag, Munkhtsetseg, Westphal, Gabriela, Berger, Irina, Gather, Katharina S, Hilbig, Heidegard, Neuhaus, Jochen, Hänsch, Gertrud M, Armbruster, Franz P, Berger, Martin R
Format: Artigo
Sprache:Inglês
Veröffentlicht: John Wiley and Sons Inc. 2017
Schlagworte:
Original Articles
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5783975/
https://ncbi.nlm.nih.gov/pubmed/29416877
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cjp2.88
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge